Abstract
An increasing number of laboratories that focus on model systems are considering drug screening. Executing a drug screen is complicated enough. But the path for moving initial hits towards the clinic requires a different knowledge base and even a different mindset. In this Editorial I discuss the importance of doing some homework before you start screening. 'Lead hits', 'patentable chemical space' and 'druggability' are all concepts worth exploring when deciding which screening path to take. I discuss some of the lessons I learned that may be useful as you navigate the screening matrix.
| Original language | English |
|---|---|
| Pages (from-to) | 1241-1244 |
| Number of pages | 4 |
| Journal | DMM Disease Models and Mechanisms |
| Volume | 9 |
| Issue number | 11 |
| DOIs | |
| State | Published - 1 Nov 2016 |
Fingerprint
Dive into the research topics of 'Drug screening using model systems: Some basics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver